Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Taylor, P. B.
Right arrow Articles by Macarron, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, P. B.
Right arrow Articles by Macarron, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Standard Operating Procedure for Assessing Liquid Handler Performance in High-Throughput Screening

Paul B. Taylor

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Stephen Ashman

Department of Assay Methodology Development, New Frontiers Science Park, Harlow, United Kingdom

Stuart M. Baddeley

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Stacy L. Bartram

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Clive D. Battle

Cheminformatics, King of Prussia, PA and Stevenage, United Kingdom

Brian C. Bond

Department of Statistical Sciences, New Frontiers Science Park, Harlow, United Kingdom

Yvonne M. Clements

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Nathan J. Gaul

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

W. Elliot McAllister

Cheminformatics, King of Prussia, PA and Stevenage, United Kingdom

Juan A. Mostacero

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Fernando Ramon

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Jamie M. Wilson

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Robert P. Hertzberg

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

Andrew J. Pope

Systems Research, King of Prussia, PA.

Ricardo Macarron

GlaxoSmithKline Pharmaceuticals, Department of Molecular Screening, King of Prussia, PA and Parque Tecnologico de Madrid, Spain and Stevenage, United Kingdom

The thrust of early drug discovery in recent years has been toward the configuration of homogeneous miniaturized assays. This has allowed organizations to contain costs in the face of exponential increases in the number of screening assays that need to be run to remain competitive. Miniaturization brings with it an increasing dependence on instrumentation, which over the past several years has seen the development of nanodispensing capability and sophisticated detection strategies. To maintain confidence in the data generated from miniaturized assays, it is critical to ensure that both compounds and reagents have been delivered as expected to the target wells. The authors have developed a standard operating procedure for liquid-handling quality control that has enabled them to evaluate performance on 2 levels. The first level provides for routine daily testing on existing instrumentation, and the second allows for more rigorous testing of new dispensing technologies. The procedure has shown itself to be useful in identifying both method programming and instrumentation performance shortcomings and has provided a means to harmonizing instrumentation usage by assay development and screening groups. The goal is that this type of procedure be used for facilitating the exchange of liquid handler performance data across the industry.

Journal of Biomolecular Screening, Vol. 7, No. 6, 554-569 (2002)
DOI: 10.1177/1087057102238630


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
I. Popa-Burke, B. Lupotsky, J. Boyer, W. Gannon, R. Hughes, P. Kadwill, D. Lyerly, J. Nichols, E. Nixon, D. Rimmer, et al.
Establishing Quality Assurance Criteria for Serial Dilution Operations on Liquid-Handling Equipment
J Biomol Screen, September 1, 2009; 14(8): 1017 - 1030.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
W. P. Janzen and I. G. Popa-Burke
Review: Advances in Improving the Quality and Flexibility of Compound Management
J Biomol Screen, June 1, 2009; 14(5): 444 - 451.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
I. Coma, L. Clark, E. Diez, G. Harper, J. Herranz, G. Hofmann, M. Lennon, N. Richmond, M. Valmaseda, and R. Macarron
Process Validation and Screen Reproducibility in High-Throughput Screening
J Biomol Screen, January 1, 2009; 14(1): 66 - 76.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
C. Quintero, C. Rosenstein, B. Hughes, R. Middleton, and I. Kariv
Quality Control Procedures for Dose-Response Curve Generation Using Nanoliter Dispense Technologies
J Biomol Screen, September 1, 2007; 12(6): 891 - 899.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
H. Rhode, M. Schulze, S. Renard, P. Zimmermann, T. Moore, G. A. Cumme, and A. Horn
An Improved Method for Checking HTS/uHTS Liquid-Handling Systems
J Biomol Screen, December 1, 2004; 9(8): 726 - 733.
[Abstract] [PDF]